07:00 , May 20, 2002 |  BioCentury  |  Finance

Ebb & Flow

Back in February, a table in BioCentury showed how much value would be lost in big cap biotech if the group's price-to-earnings multiples contracted to those of big pharma (see BioCentury, Feb. 19). At the...
08:00 , Mar 25, 2002 |  BioCentury  |  Finance

Neuro money

Neuro money Company Businesses Raised (M) Deal date Investors Memory Pharma Neurological $40.0 25-Mar-02 Biomedicine; Yamanouchi Venture Capital; Mitsubishi Corp. and affiliates; SG Cowen Ventures; BioVeda; Yasuda Development; Oxford BioScience Partners; Venrock Associates; OrbiMed...
08:00 , Feb 13, 2002 |  BC Extra  |  Financial News

Beyond Genomics raises $11 million

Beyond Genomics raised $11 million in a private round through AGTC Funds/Flagship Ventures and Gilde Biotechnology and Nutrition. Beyond Genomics (Waltham, Mass.) will use the financing to expand its systems biology research efforts, which initially...
07:00 , Aug 27, 2001 |  BC Week In Review  |  Company News

Genome Therapeutics board of directors update

Genome Therapeutics Corp. (GENE), Waltham, Mass.   Business: Genomics   Appointed: David Stone, founding partner of AGTC Funds   ...
07:00 , Apr 9, 2001 |  BC Week In Review  |  Company News

Nanostream board of directors update

Nanostream Inc., Pasadena, Calif.   Business: Microfluidics   Appointed: Devon Giacalone, principal at Techno Venture Management; and Nancy Crowell, founding partner at AGTC Funds   ...
07:00 , Apr 9, 2001 |  BC Week In Review  |  Company News

Cellular Genomics board of directors update

Cellular Genomics Inc., Branford, Conn.   Business: Genomics, Functional genomics, Proteomics   Appointed: Michael Steinmetz, general partner at MPM Capital; and Noubar Afeyan, managing partner of AGTC Funds   ...
07:00 , Apr 5, 2001 |  BC Extra  |  Financial News

Cellular Genomics raises $22 million

Genomics-based drug discovery company Cellular Genomics (Branford, Conn.) raised $22 million in a private financing. Investors included MPM Capital; AGTC Funds; Vector Fund Management; CHL Medical Partners; and Connecticut Innovations....
07:00 , Oct 23, 2000 |  BioCentury  |  Emerging Company Profile

Genomics Collaborative Inc.

Genomics Collaborative Inc. Cambridge, Mass. Technology: Repository of human DNA, serum and tissue samples Disease focus: Arthritis, asthma, cancer, cardiovascular, diabetes and osteoporosis Founded: 1998 by Michael Wall, Richard Pops, Michael Landine, Phyllis Gardner and Edward Harlow Corporate partners: Qiagen...
07:00 , Oct 12, 2000 |  BC Extra  |  Financial News

Genomics Collaborative raises $36.2 million

Genomics Collaborative ( Cambridge, Mass.), a genomics company based on large-scale association studies, raised $36.2 million in a private round. Lead investors included Invesco Private Capital; Whitney & Co; AGTC Funds; Oracle Partners; the Economic...
07:00 , Sep 26, 2000 |  BC Extra  |  Financial News

Hypnion raises $10.4 million

Hypnion raised $10.4 million in venture financing from Oxford Bioscience Partners; AGTC Funds; and GIMV. Hypnion (Worcester, Mass.) is developing functional genomics and in vivo compound screening systems for sleep disorders and related CNS disorders....